Suppr超能文献

糖化血红蛋白:糖尿病监测中的一个新因素(作者译)

[Hemoglobin A1c: a new factor in the supervision of diabetes (author's transl)].

作者信息

Maquart F X, Randoux A, Leutenegger M, Borel J P

出版信息

Ann Biol Clin (Paris). 1978;36(6):467-74.

PMID:749562
Abstract

Hemoglobin A1c is one of the minor components of normal human hemoglobin. It differs from Hb A by the presence of one molecule of glucose fixed to the N-terminal extremity of every beta chain. It is synthesized from Hb A by a very slow and only slightly reversible mechanism which continuously occurs during the 120 days of the red cell life. Hb A1c represents nearly 5% of total hemoglobin of the normal subject. In patients suffering of diabetes mellitus, its level seems to reflect closely the degree of equilibrium of the disease for 4 to 5 weeks which preceeded the evaluation.

摘要

糖化血红蛋白A1c是正常人血红蛋白的次要成分之一。它与血红蛋白A的不同之处在于,每个β链的N末端都固定有一个葡萄糖分子。它由血红蛋白A通过一种非常缓慢且仅略微可逆的机制合成,这种机制在红细胞120天的生命周期中持续发生。糖化血红蛋白A1c占正常受试者总血红蛋白的近5%。在糖尿病患者中,其水平似乎密切反映了评估前4至5周疾病的平衡程度。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验